Literature DB >> 8195014

The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities.

J A Bonner1, N J Maihle, B R Folven, T J Christianson, K Spain.   

Abstract

PURPOSE: This study was performed to characterize the interaction of epidermal growth factor and radiation in two human head and neck squamous cell cancer cell lines of vastly different radiosensitivities (UM-SCC-6 Radiosensitive; UM-SCC-1 radioresistant). METHODS AND MATERIALS: The two human head and neck squamous cell cancers (UM-SCC-1 and UM-SCC-6) were grown in medium and following the appropriate treatments, cell survival was assessed by a standard colony formation assay. Growth inhibition was assessed by monitoring cell counts following treatment and flow cytometry was used to assess cell cycle distributions. RESULTS AND
CONCLUSION: It was determined that exposure to epidermal growth factor (10 ng/ml) for 24 h prior to radiation resulted in radiosensitization in both cell lines, however, the magnitude of radiosensitization was greater in the radiosensitive UM-SCC-6 cells compared to the radioresistant UM-SCC-1 cells. Treatment of the UM-SCC-6 cells with epidermal growth factor (EGF) (10 ng/ml) for 24 h resulted in a growth delay, however, cell growth returned to normal approximately 24 h following removal of EGF. Similar treatment of the UM-SCC-1 cells resulted in no growth inhibition. The 24 h pre-radiation exposures to EGF (10 ng/ml) did not affect the radiation-induced growth delay in either cell line. Additionally, the 24 h exposures to EGF (10 ng/ml) did not affect the radiation-induced growth delay in either cell line. Additionally, the 24 h exposures to EGF (10 ng/ml) did not cause the cells to enter a more radiosensitive cell cycle phase. Further work will be necessary to determine whether events associated with the EGF-induced growth delay in the UM-SCC-6 cells are associated with the enhanced EGF-induced radiosensitization in these cells compared to UM-SCC-1 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195014     DOI: 10.1016/0360-3016(94)90269-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  32 in total

1.  Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro.

Authors:  Hui Liu; Yufeng Li; Kevin P Raisch
Journal:  Anticancer Drugs       Date:  2010-10       Impact factor: 2.248

2.  Noncovalent assembly of targeted carbon nanovectors enables synergistic drug and radiation cancer therapy in vivo.

Authors:  Daisuke Sano; Jacob M Berlin; Tam T Pham; Daniela C Marcano; David R Valdecanas; Ge Zhou; Luka Milas; Jeffrey N Myers; James M Tour
Journal:  ACS Nano       Date:  2012-02-16       Impact factor: 15.881

3.  Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases.

Authors:  Leandro C A Cerchietti; Marcelo R Bonomi; Alfredo H Navigante; Monica A Castro; Maria E Cabalar; Berta M C Roth
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

Review 4.  New Therapies in Head and Neck Cancer.

Authors:  Rodell T Santuray; Daniel E Johnson; Jennifer R Grandis
Journal:  Trends Cancer       Date:  2018-04-19

5.  Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.

Authors:  Takashi Yamatodani; Lars Ekblad; Elisabeth Kjellén; Anders Johnsson; Hiroyuki Mineta; Johan Wennerberg
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-24       Impact factor: 4.553

6.  Noncovalent functionalization of carbon nanovectors with an antibody enables targeted drug delivery.

Authors:  Jacob M Berlin; Tam T Pham; Daisuke Sano; Khalid A Mohamedali; Daniela C Marcano; Jeffrey N Myers; James M Tour
Journal:  ACS Nano       Date:  2011-07-15       Impact factor: 15.881

7.  [Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma].

Authors:  J Dvorak; V Sitorova; A Ryska; I Sirak; I Richter; J Hatlova; A Ferko; B Melichar; J Petera
Journal:  Strahlenther Onkol       Date:  2012-08-01       Impact factor: 3.621

8.  Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma.

Authors:  James A Bonner; Hoa Q Trummell; Christopher D Willey; Brian A Plants; Kevin P Raisch
Journal:  Radiother Oncol       Date:  2009-07-16       Impact factor: 6.280

Review 9.  Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancer.

Authors:  Josephine Feliciano; Steven Feigenberg; Minesh Mehta
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

Review 10.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.